Respiratory Virus Vaccine Update: AAFP Board Chair Details ACIP 2024-25 Recommendations

As the 2024-2025 respiratory virus season approaches, the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recently released updated recommendations for immunization against COVID-19, influenza, and respiratory syncytial virus (RSV). In light of the new recommendations, Patient Care Online sat down with Tochi Iroku-Malize, MD, board chair of the American Academy of Family Physicians to discuss them in more detail, including how the updated vaccines differ from previous years and how the ACIP’s decision to remove the “shared clinical decision making” recommendation for RSV vaccination impacts primary care clinicians.

Tochi Iroku-Malize, MD, MPH, a family physician in Long Island, New York, is the board chair of the American Academy of Family Physicians. Iroku-Malize serves as founding chair and professor of family medicine for the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New York, and is senior vice president and chair of the family medicine service line for Northwell Health. She was previously the director of the family medicine residency program at Southside Hospital in Bay Shore, New York. She is currently a member of the Society of Teachers of Family Medicine and is active in the Association of Departments of Family Medicine.